LentiCRISPR v2 RB1 sgRNA #1 Citations (1)

Originally described in: RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.
Wang ME, Chen J, Lu Y, Bawcom AR, Wu J, Ou J, Asara JM, Armstrong AJ, Wang Q, Li L, Wang Y, Huang J, Chen M J Clin Invest. 2023 Mar 16:e166647. doi: 10.1172/JCI166647. PubMed Journal

---

Articles Citing LentiCRISPR v2 RB1 sgRNA #1

Articles
High cereblon expression in neuroendocrine cancer confers vulnerability to GSPT1 molecular glue degrader. Park J, Joo MS, Kim MJ, Oh S, Tran PT, Kwon M, Choi YJ, Lee J, Kim EJ, Ki DH, Choi H, Han W, Kang KW. Exp Hematol Oncol. 2025 Jun 23;14(1):89. doi: 10.1186/s40164-025-00674-z. PubMed

If you have published an article using this material, please email us at to have your article added to this page.